SALUS, Ljubljana, d. d. (LJSE:SALR)

Market Cap	460.28M +122.9%
Revenue (ttm)	673.54M +4.9%
Net Income	14.48M +11.1%
EPS	1.76 +10.5%
Shares Out	8.22M
PE Ratio	31.84
Forward PE	n/a
Dividend	1.20 (2.14%)
Ex-Dividend Date	Jan 15, 2026

Volume	531
Average Volume	680
Open	57.00
Previous Close	56.00
Day's Range	56.00 - 57.00
52-Week Range	27.18 - 58.00
Beta	0.42
RSI	83.02
Earnings Date	Feb 27, 2026

About SALUS, Ljubljana, d. d.

SALUS, Ljubljana, d. d. engages in the distribution, promotion, sales services, and value-added services for medicinal products or medical devices in Slovenia and internationally. The company offers commercial partnerships to pharmaceutical, biotechnology, consumer healthcare, and medical device companies; and medicinal products, medical devices, sanitary products, dietary supplements, cosmetics, pharmaceutical packaging, and other products to pharmacies, hospitals, community health centers, residential homes for the elderly, veterinary institu...

• Industry: Drugs, Drug Proprietaries, and Druggists' Sundries
• Founded: 1969
• Employees: 618
• Stock Exchange: Ljubljana Stock Exchange
• Ticker Symbol: SALR

Financial Performance

In 2024, SALUS, Ljubljana, d. d.'s revenue was 648.83 million, an increase of 8.24% compared to the previous year's 599.44 million. Earnings were 12.85 million, an increase of 25.14%.